Multiple sclerosis is an inflammatory disease in which the fatty myelin sheaths around the axons of the brain and spinal cord are damaged, leading to demyelination and scarring as well as a broad spectrum of signs and symptoms. MS affects the ability of nerve cells in the brain and spinal cord to communicate with each other effectively.
By Anthony Rivas | May 13, 2013 10:08 PM EDT
Three dispensaries in Washington D.C. are preparing to open later on this month, even with the Department of Justice cracking down on dispensaries across the country.
By Sabrina Bachai | May 11, 2013 02:21 PM EDT
Researchers in Tokyo find that there is no correlation between bidet usage and preterm labor.
By Ansa Varughese | May 06, 2013 05:08 PM EDT
Researchers claim that African Americans have 47 percent greater risk of developing multiple sclerosis (MS) compared to whites, contrary to what was previously thought. Black women have a higher risk compared to racial, ethnic, and gender groups.
By Susan Scutti | Apr 22, 2013 02:33 PM EDT
Chrissy Amphlett, lead singer of the Australian band Divinyls, faced a battle on two fronts with cancer and multiple sclerosis.
By Evan Winchester | Apr 20, 2013 09:52 AM EDT
More and more scientific studies are proving the therapeutic uses of medical marijuana. Currently legal in 18 states plus D.C., it may be only a matter of time before medical marijuana is legal everywhere in the country.
By Jonathan Weiss | Apr 15, 2013 12:06 PM EDT
By reprogramming skin cells into myelin producing cells and proving they work, researchers are forging ahead in hopes of repairing damage seen in some neurological diseases.
By Ashik Siddique | Apr 08, 2013 08:13 PM EDT
Annette Funicello, former Disney Mouseketeer, died at the age of 70 from complications of progressive multiple sclerosis, which she battled for over two decades before effective treatments were possible.
By Ansa Varughese | Apr 03, 2013 02:16 PM EDT
A shift in 'amyloid-is-bad' dogma. How could a protein associated with Alzheimer's and other neurodegerative diseases actually help?
By Matthew Mientka | Mar 30, 2013 01:49 PM EDT
An American pharmaceutical company said yesterday it would discount a drug treatment for multiple sclerosis expected to generate more than $3 billion in sales. Biogen Idec Inc., of Weston, MA, said it would charge $54,900 per year for Tecfidera, which U.S. regulators approved Wednesday.
By Ashik Siddique | Mar 27, 2013 10:40 PM EDT
Two innovative multiple sclerosis treatments, bone marrow transplantation and a newly FDA-approved drug called Tecfidera, give patients hope for preventing relapses.
By Ashik Siddique | Mar 22, 2013 06:00 PM EDT
The genes that lead to autoimmune inflammatory diseases like MS, Crohn’s disease, and rheumatoid arthritis may have actually benefited our early ancestors– more evidence for the hygiene hypothesis.
By Jonathan Weiss | Mar 20, 2013 09:47 AM EDT
A modification of a current treatment will allow patients to go longer between dosages and have a better quality of life with the same benefits as the regular drug.
By Jonathan Weiss | Mar 18, 2013 10:01 AM EDT
Touted by an Italian surgeon as a simple procedure that could stop the neurodegenerative disease dead in its tracks, a new clinical trial casts doubt on its effectiveness and even calls it damaging.
By Jonathan Weiss | Mar 06, 2013 02:39 PM EST
Using research on inflammatory Th17 cells, researchers have shown both in cells and in a mouse model of Multiple Sclerosis that increased salt intake can promote autoimmune disease.
By Christine Hsu | Jan 30, 2013 08:47 PM EST
Obesity may significantly increase the risk of developing multiple sclerosis in children and adolescent girls, a new study has revealed.